53
Curriculum Vitae Dr. Ali Eslamifar 1 BIOGRAPHICAL Name: Ali Eslamifar, M.D., ACP Professor of Pathology.Head of the Clinical Research Dept. of the Pasteur Institute of IranAddress: Electron Microscopy and Clinical Research Department, Pasteur Institute of Iran (IPI), No. 69, Pasteur Ave., Tehran 1316943551, Iran Birth Date: September , 06, 1962 Tel/fax: +98-21 64112805 Mobile: +98-912 1095759 E-mail: [email protected] , [email protected] EDUCATION Years attended 1989-1996 Degree or received MD Institution Shaheed Beheshti University of Medical Sciences and Health Services Years attended 1997-2001 Degree or received Anatomical & Clinical Pathology (ACP) Institution Shaheed Beheshti University of Medical Sciences and Health Services Years attended 2001 Degree or received Electron microscopy Institution Shaheed Beheshti University of Medical Sciences and Health Services

Curriculum Vitae Dr. Ali Eslamifar

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

1

BIOGRAPHICAL

Name: Ali Eslamifar, M.D., ACP

“Professor of Pathology.Head of the Clinical Research Dept. of the Pasteur Institute of Iran”

Address: Electron Microscopy and Clinical Research Department, Pasteur Institute of Iran (IPI), No. 69,

Pasteur Ave., Tehran 1316943551, Iran

Birth Date: September , 06, 1962

Tel/fax: +98-21 64112805

Mobile: +98-912 1095759

E-mail: [email protected] , [email protected]

EDUCATION Years attended 1989-1996

Degree or received MD

Institution Shaheed Beheshti University of Medical Sciences and Health Services

Years attended 1997-2001

Degree or received Anatomical & Clinical Pathology (ACP)

Institution Shaheed Beheshti University of Medical Sciences and Health Services

Years attended 2001

Degree or received Electron microscopy

Institution Shaheed Beheshti University of Medical Sciences and Health Services

Page 2: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

2

Executive Records Organization Positions Row

Pasteur Institute of Iran Director and Head of Clinical Research Dept. 1

Pasteur Institute of Iran Director of clinical research, epidemiology and

biostatistics at the Pasteur Institute of Iran 2

Pasteur Institute of Iran Head of vaccination Dept 3

Pasteur Institute of Iran Director and Head of Electron Microscopy Dept 4

Pasteur Institute of Iran Medical Ethics Committee 5

Pasteur Institute of Iran Deputy Director for Specialized Sceintific Services 6

Page 3: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

3

Publications ISI (International):

Cod

Title Authors Journal Information

Journal Name IF Date No

1

Assesment of the association between human

Papillomavirus infection and breast carcinoma

Ali Eslamifar, Amitis Ramezani, Kayhan Azadmanesh, Farahnaz Bidari-

Zerehpoosh, Mohammad Banifazl, Arezoo Aghakhani

Iranian Journal of Patholpgy ISI

2015

(2015)

10 (

1)

2 Lack of human papillomavirus DNA in colon

adenocarcinama and adenoma

Arezoo Aghakhani, Rasool Hamkar, Amitis Ramezani, Farahnaz Bidari- Zerehpoosh,

Shahram Sabeti, Nastaran Ghavami Mohammad Banifazl, Niloofar Rashidi,

Ali Eslamifar

Journal of Cancer Research and Therapeutics

ISI

2015

Volu

me

10 -

Iss

ue

3

3

Neutralizing Antibody Response after Intramuscular

Purified Vero Cell Rabies Vaccination (PVRV) in Iranian

Patients with Specific Medical Conditions

Rahimi P, Vahabpour R, Aghasadeghi MR, Sadat SM, Howaizi N, Mostafavi E,

Eslamifar A, Fallahian V PLOS ONE ISI

2015

DO

I:10.1

371

Page 4: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

4

4

Occult hepatitis C virus infection in Iranian hemodialysis

patients

Ali Eslamifar · Amitis Ramezani · Hassan Ehteram · Effat Razeghi ·

Farrokhlagha Ahmadi · Manouchehr Amini · Mohammad Banifazl · Gelavizh

Etemadi · Hossein Keyvani · Anahita Bavand · Arezoo Aghakhani

Journal of Nephropathology ISI

2015

2015;4

(4):

116

-120

5 Frequency and Genotype of Human Parvovirus B19

Among Iranian Patients Infected With HIV

Kayhan Azadmanesh · Minoo Mohraz · Monireh Kazemimanesh · Aghakhani ·

Maryam Foroughi · Mohammad Banifazl, · Ali Eslamifar , Amitis Ramezani

Journal of Medical Virology ISI

2015

87:1

124

–1129

6

Lack of Association between Interleukin-10 Gene

Promoter Polymorphisms with HIV Susceptibility and

Progression to AIDS

Amitis Ramezani · Ebrahim Kalantar · Arezoo Aghakhani · Mohammad

Banifazl · Maryam Foroughi · Soudabeh Hosseini · Ali Eslamifar · Ali

Esmaeilzadeh · Porisa Sadrpoor · Minoo Mohraz

Iranian Journal of Pathology ISI

2015

10 (

2),

141 -

148

7

Bariatric Surgery for Morbid Obesity: Tehran

Obesity Treatment Study (TOTS) Rationale and

Study Des

M Barzin, F Hosseinpanah, MA Motamedi, P Shapoori, P Arian, MA

Daneshpour, G Asghari, A Teymoornejad, A Eslamifar, D Khalili, B Jodeiri, S Alamdari, F Azizi, A Khalaj

JMIR Res Protoc ISI

2015

5(1

): e

8

8 Immune Response to Standard Hepatitis B

Vaccination in HIV - Infected Patients

Amitis Ramezani , Minoo Mohraz, Mohammad Banifazl, Maryam Foroughi

Ali Eslamifar Arezoo Aghakhani Vaccine Research ISI

2015

Volu

me1

-N

um

ber

2

Page 5: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

5

9 Prevalence of BK virema in Iranian hemodialysis

and peritoneal dialysis pationts

Sharif A, Sharif MR, Aghakhani A, BanifazlM, Hamkar R, Ghavami N, Eslamifar A,

Ramezani A

Vaccine Research ISI 2015

Volu

me1

-N

um

ber

2

10 Identification of the main allergen sensitizers in an

Iran asthmatic population by molecular diagnosis

Fardis Teifoori Masoomeh Shams-Ghahfarokhi, Idoia Postigo, Mehdi Razzaghi-Abyaneh, Ali Eslamifar,

Antonio Gutiérrez, Ester Suñén and Jorge Martínez

Allergy, Asthma & Clinical Immunology ISI

2014

2014, 10:4

1

11 Hematological Reference Values for Healthy Males

in the Central Part of Iran

Amitis Ramezani1, Mandana Shams, Zarinfar, Mohammad Banifazl, Arezoo Aghakhani, Ali Eslamifar, Fatemeh- Alsadat Mahdaviani, Ghorban Deiri ,

Masoomeh Sofian

Iranian Journal of Pathology ISI

2014

9 (

1),

50

- 55

12

Efficacy of Cisplatin-loaded polybutyl

cyanoacrylate nanoparticles on the glioblastoma

Ebrahimi hahmabadi & ovahedi

& Maedeh Koohi Esfahani

Ali EslamifarEbrahim Alavi &

& Gholamreza Mohammadi

Anaraki & Azim Akbarzadeh

Tumor Biol ISI

2014

35:4

799

–4806

13

Serological response to one intradermal or

intramuscular hepatitis B virus vaccine booster

dose in human immunodeficiency virus-infected

nonresponders to standard vaccination

Ramezani, Alireza Janbakhsh1,

mohammadi, Mohammad

Banifazl, Arezoo Aghakhani,

rnasiri, , PouAli Eslamifar

Behzad Mahdavian, Asghar

Farazi, Masoomeh Sofian

Perspectives in Clinical Research ISI

2014

Vol

5 |

Issu

e 3

Page 6: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

6

14 Isolated Anti-HBc and Occult HBV Infection in

Dialysis Patients

Ramezani; Mohammad

Aghasadeghi; Ahmadi; Effat

*;Ali Eslamifar; Razeghi

Mohammad Banifazl;

Masoomeh Sofian; Golnaz

Bahramali; Soheila Hekmat;

Aghakhani,

Nephro Urol Mon ISI

2014

7(1

): e

22674

15 Immunity to diphtheria and tetanus among blood

donors in Arak, central province of Iran

Amitis ,Ali Eslamifar

Ramezani, Mohammad Banifaz,

Masoomeh Sofian, Fatemeh-

Alsadat Mahdaviani, Farhad

Yaghmaie, Arezoo Aghakhani

Pharmaceutical biolog ISI

2014

50, 1416

-1422

16 No evidence for occult HBV infection in hepatitis

B vaccine non-responders

Mohammad Reza Aghasadeghi,

Mohammad Banifazl, Arezoo

,Ali EslamifarAghakhani,

Rouhollah Vahabpour 1 and

Amitis Ramezani

IRAN. J. MICROBIOL ISI

2014

. V

ol.

6, N

o 5

350-3

53

17

: Immunogenicity Evaluation of a Rationally

Designed Polytope Construct Encoding HLA-

A*0201 Restricted Epitopes Derived from

Leishmania major Related Proteins in HLA-

A2/DR1 Transgenic Mice: Steps toward Polytope

Vaccines

Negar Seyed, Charline Vauchy,

Ali Magalie Dosset Yann Godet,

, Iraj Sharifi, Olivier Eslamifar

Adotevi, Christophe Borg Pierre

Simon Rohrlich, Sima Rafati1

Polytope Construct Including Leishmania

Peptides ISI

2014

Volu

me

9 |

Issu

e 10

| e108848

18

Comparison of two durations of triple-drug therapy

in patients with uncomplicated brucellosis: A

randomized controlled trial

Masoomeh Sofian · Ali-Akbar

Velayati · Arezoo Aghakhani ·

Willi McFarland · Ali-Asghar

Farazi · Mohammad Banifazl ·

· Amitis Ali Eslamifar

Ramezani

Scandinavian Journal of Infectious Diseases ISI

2014

46:

573

–577

Page 7: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

7

19

HCV, HBV, and HIV seroprevalence, coinfections,

and related behaviors among male injection

drug users in Arak, Iran

Ramezania, Reihaneh

Amirmoezib, Jonathan E. Volkc,

Aghakhania, Zarinfard,

McFarlande Banifazlf,

and Ali EslamifaraMostafavig,

Masoomeh Sofiand

dx.doi.org ISI 2014

10.1

080/0

9540121

.2014.8

82485

20

Hepatitis E virus infection in patients infected with

human immunodeficiency virus in an endemic area

in Iran

Amitis Ramezani, Velayati, -

, Ali EslamifarSarvestani,

Minoo Mohraz4, Mohammad

Banifazl5, Farahnaz Bidari-

Zerehpoosh6, Farhad

Yaghmaei1, Willi McFarland7,

Maryam Foroughi4, Hossein

Keyvani8, Ehsan Mostafavi and

Arezoo Aghakhani

International Journal of STD & AIDS ISI

2014

24(1

0)

21

The Effect of Candida Albicans Systemic Infection

on Matrix Metalloproteinases in Breast Cancer

Bearing Balb/c Mice

Fatemeh Hajari Taheri,

Seyedolmohadesin , Mansour

Bayat, Mahdavi, Mohammad

and Ali EslamifarYazdi,

Mohsenv bolhassani

Iran J Allergy Asthma Immunol ISI

2013

12(1

):81

-85

22

Frequency and Genotype of Hepatitis D Virus

Infection in Patients Infected with HIV and Those

Undergoing Hemodialysis

Aghasadeghi 1, Mohraz 2,

Golnaz Bahramali 1, Aghakhani

3, Banifazl 4, Maryam Foroughi

Ali 2, Farrokhlagha Ahmadi 5,

Mehdi Sadat 1, Eslamifar*,

Ramezani 3

Hepat Mon ISI

2013

13(5

):e7

481

23

No Correlation Between Interleukin-10 Gene

Promoter Polymorphisms and Hepatitis B Virus

Infection Outcome

Masoomeh Sofian, Ebrahim

Kalantar, Arezoo Aghakhani,

Soudabeh Hosseini, Mohammad

Ali EslamifarBanifazl,

jourabchi 5, Ali Asghar Farazi 1,

Amitis Ramezani 3

Hepat Mon. ISI

2013

13(5

):e8

803

Page 8: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

8

24 Low Prevalence of Brucella agglutinins in Blood

Donors in Central Province of Iran

Sofian1, Mehrnoosh

Sheikholeslami2, Fatemeh-

Mahdaviani3, Aghakhani4,

Ali Mohammad Banifazl5,

, Sarmadian1, Eslamifar

Ghorban Deiri3, Amitis

Ramezani

IRAN. J. MICROBIOL ISI

2013

Vol.

5, N

o. 1

(Mar

ch 2

013

), 2

4-

27

25

Seroprevalence of Hepatitis E Virus infection

among volunteer blood donors in central province

of Iran in 2012

Hassan Ehteram1, Amitis

, EslamifarAli Ramezani2,

Masoomeh Sofian3, Mohammad

Banifazl4, Shahin Ghassemi5,

Arezoo Aghakhani2, Parisa

Mashayekhi

IRAN. J. MICROBIOL. ISI

2013

Vol.

5,

No. 2

(June

2013),

172-1

76

26 Screening of family members of patients with acute

brucellosis in an endemic area of Iran

Masoomeh Sofian1, Leila

Safaeipour2, Arezoo

Aghakhani3, Mohammad Reza

Sharif4, Mohammad Banifazl5,

Alireza Sharif6, Ali-Asghar

,EslamifarAli Farazi1,

Farshideh Didgar1, Amitis

Ramezani

IRAN. J. MICROBIOL ISI

2013

Vol.

5, N

o. 3

(Sep

tem

ber

2013),

215-2

19

27

Importance of Isolated Anti‐HBc in Detection of

Occult Hepatitis B Virus Infection in Hemodialysis

Patients

M A Eslamifar,Ramezani,

Banifazl, A Aghakhani

Nephro Urol Mon ISI

2013

7(1

): e

22674.

28

Differentiation of Brucella -Induced Epididymo-orchitis

from Nonspe-cific Epididymo-orchitis in an Endemic Area

for Bru

cellosis

A Ramezani, Masoomeh Sofian , Arezoo

Aghakhani, Mohammad Banifazl, Ali

Eslamifar, Fatemeh Zolfaghari, Hossein

Sarmadian, Amitis Ramezani

Med Microbiol Infec Dis ISI

2013

1(1

): 8

-13

Page 9: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

9

29 Outcome of hemodialysis patients with occult

hepatitis B virus infection at a 4 year follow-up

Ramezani A, Banifazl M,

, Ahmadi F, Eslamifar A

.Aghakhani A, Razeghi E

J Gastrointestin Liver Dis. ISI

2013

2013

Mar

;22(1

):111

-2.

30

Immunomodulatory effects of IP-10 chemokine

along with PEI600-Tat delivery system in DNA

vaccination against HPV infections

Mohit E1, Bolhassani A,

Zahedifard F, Seyed N,

, Taghikhani M ,Eslamifar A

Samimi-Rad K, Rafati S

Mol Immunol. ISI

2013

07.0

11. E

pub 2

012

Aug 2

5..

31

Rabies antibody levels in pregnant women and

their newborns after rabies post-exposure

prophylaxis

Ahmad Fayaz¹ D.V.M., Susan

Ali Simani¹ Vida Fallahian

³ M.D., Mahboob ²,Eslamifar

Hazrati² M.D., Firoozeh

Farahtaj¹ M.L.D, Nader

Howaizi¹ B.Sc., Peivand Biglari¹

B.Sc

Iran J Reprod Med

ISI

2013

Vol.

10. N

o.2

.

32 Tetanus and Diphtheria Seroprevalence in Patients

Infected With Human Immunodeficiency Virus

, Amitis Ali Eslamifar1

Ramezani1, Mohammad

Banifazl2, Arezoo Aghakhani

IRANIAN JOURNAL OF PATHOLOGY ISI

2013

Vol.

7 N

o.1

, W

inte

r 2012

33 Viral hepatitis and HIV infection among injection

drug users in a central Iranian City

Sofian M1, Aghakhani A,

Banifazl M, Azadmanesh K,

Farazi AA, McFarland W,

Ramezani A, A Eslamifar

J Addict Med. ISI

2013

2012

Dec

;6(4

):292

-6

Page 10: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

10

34 No Evidence of the Th1 to Th2 Cytokine Shift

during the Course of HIV Infection

Safyeh Soufian, Arezoo

Aghakhani, Minoo Mohraz,

Ali Mohammad Banifazl,

-, Zahra BolandEslamifar

Ghamat, Akbar Khadem-

Sadeghand Amitis Ramezani2

IRANIAN JOURNAL OF PATHOLOGY ISI

2012

Vol.

7 N

o.2

, S

pri

ng

2012

35

Seroprevalence of IgG Antibodies against

Bordetella pertussis in Different Age Groups in

Tehran, Iran

, Amitis Ali Eslamifar1

Ramezani1, Mohammad

Banifazl2, Akbar Khadem-

Sadegh1, Arezoo Aghakhani1

Iranian Journal of Pathology ISI

2012

(2012)

7 (

3),

171 -

176

36

The Influence of Human Leukocyte Antigen and

IL-10 Gene Polymorphisms on Hepatitis B Virus

Outcome

Amitis Ramezani, Mohammad

Banifazl, Setareh Mamishi,

Ali , Masoomeh Sofian

, Arezoo AghakhaniEslamifar

Hepat Mon ISI

2012

2012;1

2(5

)

37 Viral Hepatitis and HIV Infection in Hemodialysis

Patients

Arezoo Aghakhani 1,

Ali Mohammad Banifazl 2,

1, Farrokhlagha Eslamifar

Ahmadi 3, Amitis Ramezani

Hepat Mon ISI

2012

2012;1

2(7

):463

-464

38 Efficacy of Eosin B as a New Antimalarial Drug in

a Murine Model

Zahra Zamani,1 Alireza Sadeghi

Tafreshi,2 Hossein

Nahrevanian,3 Behzad Lame-

Rad,2 Fatemeh Pourfallah,1

4 Sedigheh Hossein Eslamifar,

Sadeghi,1 Farideh Vahabi,1

Ayda Iravani,1 and Mohammad

Arjmand1

Malaria Research and Treatment ISI

2012

10.1

155/2

012/3

8172

4

Page 11: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

11

39

Occult hepatitis B infection in different high risk

patients

Ali Ramezani, Banifazl,

, Masoomeh rEslamifa

Sofian . Arezoo Aghakhani

Hepat Mon ISI 2012

10.5

812/h

epat

mon

.7094

40

Serum Profile of T Helper 1 and T Helper 2

Cytokines in Hepatitis C Virus Infected Patients

Masoomeh Sofian, Arezoo

Aghakhani, Ali Asghar Farazi,

Ali Mohammad Banifazl 3,

, Niloofar Rashidi 2, Eslamifar

Akbar Khadem Sadegh 2,

Amitis Ramezan

Hepat Mon ISI

2012

10.5

812/h

epat

mon.6

156

41 Occult Hepatitis B Virus Infection in Hemodialysis

Patients: A Concept for Consideration

Arezoo Aghakhani, Mohammad

Ali Banifaz, Ali Akbar Velayati,

, Amitis RamezaniEslamifar

Ther Apher ISI

2012

Vol.

16, N

o. 4,

2012

42

Characterization of human herpes virus 8

genotypes in Kaposi's sarcoma patients in Tehran,

Iran

Kayhan Azadmanesh1, Zeinab

Sadat Norouzfar1,2, Amir

Sohrabi1,3, Zahra Safaie-

Naraghi4, Afshin Moradi5,

Parichehre Yaghmaei, Mona

Masoumeh Naraghi, Arash

Ali EslamifarArashkia,

Int J Mol Epidemiol Genet ISI

2012

2012:3

(2):

144

-152

43

Do the initial serum level changes of sCD26 have ability to

predict successful treatment with IFN- among naïve

chronic hepatitis B patients?

Mostafa Alavi-Moghaddama,

Seyed Alavianb, Aalaei-

Ali EslamiFarAndabilib,

Vaccine ISI

2011

29 (

2011)

9093–

9097

Page 12: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

12

44 Serological pattern of anti-HBc alone infers occult

hepatitis B virus infection in high-risk individuals in Iran

Amitis Ramezani, Mohammad

, Arezoo Ali EslamifarBanifazl,

Aghakhani

J Infect Dev Ctries ISI 2011

4(1

0):

658-6

61

45 Association between Human Papillomavirus Infection and

Risk of Prostate Cancer

Amitis Ramezani, Mohammad

, Arezoo Ali EslamifarBanifazl,

Aghakhani

Iranian Journal of Pathology ISI

2011

6 (

1),

3 -

7

46

Persistence of antibody to hepatitis B surface antigen

among vaccinated children in a low hepatitis B virus

endemic area

Arezoo Aghakhani, Mohammad

Banifazl, Nabiallah Izadi, Willi

McFarland, Masoomeh Sofi an,

Akbar Khadem-Sadegh, Zahra

Pournasiri, Maryam Foroughi,

, Amitis Ali Eslamifar

Ramezani

World J Pediatr ISI

2011

Vol

7 N

o 4

N

ovem

ber

15, 2011

47 Isolation of Cupriavidus Metallidurans from Razor Blade during Paraffin Embedded Tissue Sectioning

Sohrabi A, Norouzfar ZS,

, Arashkia A ,Eslamifar A

Azadmanesh K

Int J Mol Epidemiol Genet ISI

2011

2012:3

(2):

144

-152

48

In Silico Analysis of Six Known Leishmania major

Antigens and In Vitro Evaluation of Specific

Epitopes Eliciting HLA-A2 Restricted CD8 T Cell

Response

Negar Seyed1, Farnaz

Zahedifard1, Shima Safaiyan1,

Elham Gholami1, Fatemeh

Doustdari1, Maryam Mirzaei3,

Nasir Saeedi Eslami, Akbar

Ali Eslami Khadem Sadegh,

, Iraj Sharifi, Sima Rafati1far

Int J Mol Epidemiol Genet ISI

2011

2012:3

(2):

144

-152

Page 13: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

13

49 Comparison of QuantiFERON TB-G-test to TST for

detecting latent tuberculosis infection in a high-incidence

area containing BCG-vaccinated population

. Amina Kariminia, Zarin

Sharifnia, Aghakhani, Banifazl ,

Mahboob Ali Eslamifar,

Hazrati and Amitis Ramezani

Journal of Evaluation in Clinical Practice ISI

2010

15 (

2009)

148–

151

50 Assessing subtype and drug-resistance-associated

mutations among antiretroviral-treated HIV-infected

patients

Rasool Hamkara, Minoo

Mohrazb, Shima Lorestanic,

Arezoo Aghakhanid, Hong-Ha

M. Truonge, Willi McFarlande,

Ali Mohammad Banifazlf,

Maryam Foroughib, , amifarEsl

Atessa Pakfetratg and Amitis

Ramezanid

AIDS ISI 2

010

Vol

24 (

suppl

2)

51 Occult Hepatitis B Virus Infection in Hemodialysis

PatientsWith Isolated Hepatitis B Core Antibody: A

Multicenter Study

Arezoo Aghakhani,1

Mohammad Banifazl, Ebrahim

, , Ali EslamifarKalantar

Farrokhlagha Ahmadi, Effat

Razeghi,Shahnaz Atabak,

Manouchehr Amini, Akbar

Khadem-Sadegh, and Amitis

Ramezani1

Ther Apher Dial ISI

2010

Vol.

14, N

o. 3

52 Lack of occult hepatitis B virus infection among blood

donors with isolated hepatitis B core antibody living in an

HBV low prevalence region of Iran

Masoomeh Sofian , Arezoo

Aghakhani , Nabiallah Izadi ,

Mohammad Banifazl , Ebrahim

, Ali EslamifarKalantar ,

Amitis Ramezani

International Journal of Infectious Diseases ISI

2010

14 (

2010)

e308

–e3

10

Page 14: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

14

53 Surface gene mutations of hepatitis B virus among high-

risk patients with occult hepatitis B virus infection

Rasool Hamkara, Arezoo

Aghakhanib, Safyeh Soufianc,

Mohammad Banifazld, Nastaran

Ghavamia, Mahsa Nadria,

Masoomeh Sofiane,

Farrokhlagha Ahmadia, Effat

, Amitis Ali EslamifarRazeghia,

Ramezanib

Diagnostic Microbiology and Infectious Disease

ISI

2010

66 (

2010)

285

–291

54 Effect of Matricaria chamomilla L. flower essential oil on the growth

and ultrastructure of Aspergillus niger van Tieghem,

Marziyeh Tolouee , Soheil

, Ali Alinezhad , Reza Saberi b

, Seyed Javad Zad , Eslamifar

Kamkar Jaimand , Jaleh Taeb ,

ohammad-Bagher Rezaee ,

Masanobu Kawachi , Masoomeh

Shams-Ghahfarokhi, Mehdi

Razzaghi-Abyaneh

Journal of Food Microbiology ISI

2010

139 (

2010)

127

–133

55 Seroe pidemiology of hepatitis Avirus in children of

different gegroupsin Tehran,Iran: Implications for

healthpolicy

Masoomeh Sofian

ArezooAghakhani , Ali-

AsgharFarazi , Mohammad

Banifazl , GelavizhEtemadi ,

SaeedAzad-Armaki, Abolhassan

Ziazarifi, ZohrehAbhari,

Akbar Sadegh, AliEslamifar,

NabiallahIzadi, mitis Ramezani

Travel Medicine and Infectious Disease ISI

2010

(2010)

8, 176e1

79

56 In vitro Co-Culture of Human Skin Keratinocytes and

Fibroblasts on a Biocompatible and Biodegradable

Scaffold

Seyed Ramin Pajoum Shariati

&, Mohammad Ali Shokrgozar,

Ali Manouchehr Vossoughi and

Eslamifar

Iranian Biomedical Journal ISI

2009

13 (

3):

169

-177

Page 15: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

15

57 Hepatitis B virus genotype in Iranian patients with

hepatocellular carcinoma

Arezoo Aghakhani, Rasool

Ali Hamkar, Nastaran Zamani,

Mohammad Eslamifar,

Banifazl, Alireza Saadat,

Masoomeh Sofian, Ladan Adibi,

Nemat Irani, Matin Mehryar,

Hassan Mohammad Hosseini

Akbari , Seyed Mohammad

Javad Purkhayat , Amitis

Ramezani

International Journal of Infectious Diseases ISI

2009

13, 685—

689, 2009

58 Proteinuria Is Reduced by Inhibition of Inducible Nitric

Oxide Synthase in Rat Renal Ischemia-Reperfusion Injury

M. Kadkhodaee, M.

Zahmatkesh, H.R. Sadeghipour,

J. Taeb, A. A. Eslamifar,

Shams, and M. Mahdavi-

Mazdeh

Transplantation Proceedings ISI

2009

41, 2907–2909

59 Fungistatic effects of optical brightener 220 against

Trichophyton tonsurans, Aspergillus fumigatus and

Candida albicans.

Sadeghi G, Khaksar AA, Bassiri

A, Jahromi S, Amirkhani

A, Ajdary S, Katiraee Eslamifar

F, Taeb J, Paskiabi FA, Sayyah

M.

J Dermatolog Treat. ISI

2009

20(2

):120

-3

60 Comparison of QuantiFERON TB-G-test to TST for detecting latent tuberculosis infection in a high-

incidence area containing BCG -vaccinated population.

Kariminia A, Sharifnia Z,

Aghakhani A, Banifazl M,

Hazrati M, Eslamifar A,

Ramezani A.

J Eval Clin Pract. ISI

2009

Feb

;15(1

):148

-51

Page 16: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

16

61 HLA-A *3303* and *3301 predispose patients to persistent hepatitis B infection.

Ramezani A, Aghakhani A,

Kalantar E, Banifazl M,

, Velayati AAEslamifar A

J Gastrointestin Liver Dis ISI

2009

8(1

):117

-8

62 Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.

Ramezani A, Mohraz M,

Aghakhani A, Banifazl M,

Sadegh -, KhademEslamifar A

A, Velayati AA.

Int J STD AIDS. ISI

2009

May

;20(5

):336

-8

63 In vitro co-culture of human skin keratinocytes and fibroblasts on a biocompatible and biodegradable

scaffold.

Pajoum Shariati SR, Shokrgozar MA,

Vossoughi M, Eslamifar A. Iran Biomed J. ISI

2009

Jul;

13(3

):169

-77

64 Intra/extracellular biosynthesis of silver nanoparticles

by an autochthonous strain of Proteus mirabilis isolated from photographic waste.

Samadi N, Golkaran D, Eslamifar A,

Jamalifar H, azeli MR, Mohseni FA.

J Biomed Nanotechnol ISI

2009

Jun;5

(3):

247

-53.

65

Cytotoxic effect of drugs eluted from

polymethylmethacrylate on stromal giant-cell tumour cells

D. Gouran Savadkoohi,

P. Sadeghipour,H. Attarian,

S. Sardari,A. Eslamifar,

M. A. Shokrgozar

The Journal of Bone & Joint ISI

2008

VO

L. 90-B

, N

o. 7,

JUL

Y 2

008

Page 17: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

17

65 Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.

zadmanesh K, Mohraz M,

Aghakhani A, Edalat R, Jam S,

Banifazl M, A, Eslamifar

Moradmand-Badie B, Ramezani

A.

Intervirology. ISI 2008

51(4

):270

-4.

66 Frequency of hepatitis G virus infection among HIV

positive subjects with parenteral and sexual exposure.

Ramezani A, Mohraz M,

Vahabpour R, Jam S, Banifazl

A, Mahboudi F, EslamifarM,

Aghakhani A, Edalat R, Hekmat

S.

J Gastrointestin Liver Dis. ISI

2008

Sep

;17(3

):269

-72.

67 Frequency and genotype of GB virus C among Iranian patients infected with HIV.

Hekmat S, Mohraz M,

Vahabpour R, Jam S, Bahramali

G, Banifazl M, Aghakhani A,

oudi F, , MahbA Eslamifar

Edalat R, Ramezani A.

J Med Virol ISI

2008

Nov;8

0(1

1):

1941-

6

68 Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection.

Ramezani A, Hasanjani Roshan

, A EslamifarMR, Kalantar E,

Banifazl M, Taeb J, Aghakhani

A, Gachkar L, Velayati AA.

J Gastroenterol Hepatol. ISI

2008

Nov;2

3(1

1):

1716

-21

69 Cytotoxic effect of drugs eluted from

polymethylmethacrylate on stromal giant-cell tumour cells: an in vitro study.

Savadkoohi DG, Sadeghipour P,

EslamifarAttarian H, Sardari S,

A, Shokrgozar MA.

J Bone Joint Surg Br. ISI

2008

Jul;

90(7

):973

-9

Page 18: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

18

70 Frequency and associated factors of proteinuria in Iranian HIV-positive patients.

amezani A, Mohraz M, Banifazl

M, Jam S, Gachkar L, Yaghmaie

A, Zadsar M, EslamifarF,

Kalantar N, Nemati K, Haghighi

M, Rezaie M, Aghakhani A.

Int J Infect Dis ISI 2008

Sep

;12(5

):490

-4.

71 Persistence of hepatitis B vaccine immunity in hemodialysis patients.

Ramezani A, Velayati AA,

, Banifazl M, A Eslamifar

Ahmadi F, Maziar S, Razeghi E,

Kalantar E, Amirkhani A,

Aghakhani A.

Ther Apher Dial. ISI

2008

Apr;

12(2

):143

-6

72 Animal bites in Tehran, Iran.

, Ramezani A, A slamifar

Razzaghi-Abyaneh M, Fallahian

V, Mashayekhi P, Hazrati M,

Askari T, Fayaz A, Aghakhani

A.

Arch Iran Med. ISI

2008

Mar

;11(2

):200

-2.

73 Frequency and Identification of Fungal Strains in Patients

with Chronic Rhinosinusitis

Ali Eslamifar1, Mehdi Razzaghi-

Abyaneh2, Mohsen Vazir- ezami3,

Habibollah Moghadasi3,

Amitis Ramezani1, Masoomeh Shams-

Ghahfarokhi4, Ali hameneh5,

Mohammad Ali

Shokrgozar6, Ali Akbar mir-

Zargar7, Zahra Deljoodokht1,

Arezoo Aghakhani1

Iranian Journal of Pathology ISI

2008

(2008)3 (3), 135 -

139

74 High Blood Mercury Levels in Iranian Infants:A Cause for

Concern

Amitis RamezaniAli Eslamifar Latif

Gachkar1, Zahra Pournasiri3,

MohammadBanifazl4, Arezoo

Aghakhani2, Mohammad Rabbani5,

Mohammad Amin Faghih5Soroush

Sardari6 , Ali Akbar Velayati7

Iranian Journal of Pathology ISI

2008

2008)3

(4),

186-

190

Page 19: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

19

75

Association Between HLA-A, B, DRB1 Alleles and

Susceptibility or Resistance to Chronic Hepatitis B

A. Ramezani · M. R. Hasanjani Roshan ·

E. Kalantar · A. Eslamifar · M. Mohraz ·

M. Banifazl · A. Aghakhani · J. Taeb · A.

A. Velayati

International Journal of Infectious Diseases ISI

2008

75

Long Term Immune Response to Hepatitis B Vaccine in

Haemodialysis Patients

A. Ramezani · A. Eslamifar · M. Mohraz

· M. Banifazl · F. Ahmadi · S. Maziar · E.

Razeghi · E. Kalantar · M. Hazrati · A.

Amirkhani · A. Aghakhani

nternational Journal of Infectious Diseases ISI

2008

77

Comparison of IFN-Gamma Assay and Tuberculin Skin

Test for Detecting Latent Tuberculosis Infection in BCG-

Vaccinated Population

A. Ramezani · A. Kariminia · M. Mohraz

· M. Banifaz · Z. Sharifnia · A. Eslamifar

· M. Hazrati · A. Aghakhani

International Journal of Infectious Diseases ISI

2008

78

Fungistatic effects of optical brightener 220 against

Trichophyton tonsurans, Aspergillus fumigatus and

Candida albicans

Golnar Sadeghi · Ali Asghar Khaksar ·

Shahindokht Bassiri Jahromi · Aref

Amirkhani · Ali Eslamifar · Soheila

Ajdary · Farzad Katiraee · Jaleh Taeb ·

Farnoosh Asghari Paskiabi · Mohammad

Sayyah

Journal of Dermatological

Treatment ISI

2008

20(2

):120

-3 · D

ecem

ber

2008

79 Anemia Prevalence and Related Factors in HIV-Infected

Patients: A Cohort Study

Amitis Ramezani1, Arezoo Aghakhani1,

Mohammad Reza Sharif2, Mohammad

Banifazl3,

Ali Eslamifar1, Ali Akbar Velayati4

Iranian Journal of Pathology

ISI

2008

(2008)3

(3),

125

- 128

Page 20: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

20

80 Efficacy and long-term immunogenicity of hepatitis B

vaccine in haemodialysis patients.

A, EslamifarA, amezani

Banifazl M, Ahmadi F, Maziar

S, Razeghi E, Kalantar E,

Amirkhani A, Aghakhani A.

Int J Clin Pract. ISI 2007

Mar

;63(3

):394

-7

81 Hepatitis G virus exposure in dialysis staff.

, Hamkar R, A Eslamifar

Ramezani A, Ahmadi F,

Gachkar L, Jalilvand S, Adibi L,

Khameneh A, Atabak S,

Ghadimi R, Aghakhani A.

Ther Apher Dial. ISI

2007

Oct

;11(5

):370

-4.

82 Hepatitis G virus exposure in dialysis patients.

, Hamkar R, A Eslamifar

Ramezani A, Ahmadi F,

Gachkar L, Jalilvand S, Adibi L,

Atabak S, Khameneh A,

Ghadimi R, Aghakhani A.

Int Urol Nephrol. ISI

2007

;39(4

):1257

-63

83 Risk factors for human brucellosis in Iran: a case-control

study.

Sofian M, Aghakhani A,

, Velayati AA, Banifazl M

Ramezani A., A Eslamifar

Int J Infect Dis ISI

2007

Mar

;12(2

):157

-61

84 Detection of hepatitis G virus envelope protein E2

antibody in blood donors.

Ramezani A, Gachkar L,

Khoshbaten M, A, Eslamifar

Jalilvand S, Adibi L, Salimi V,

Hamkar R.

Int J Infect Dis. ISI

2007

Jan;1

2(1

):57

-61.

Page 21: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

21

85 Antimicrobial Susceptibility Pattern of Clinical Isolates

ofPseudomonas Aeruginosa in a Pediatric Hospital

Sara Jam1, Duman Sabzevari1, Arezoo

Aghakhani2, Ali Eslamifar2Mohammad

Banifazl3, Amitis Ramezani2

Iranian Journal of Pathology ISI

2007

(2007)2

(4),

144

-148

86 Metabolic Abnormalities in HIV-Positive Patients

Receiving Highly Active Antiretroviral Therapy

Amitis Ramezani1, Minoo Mohraz2,

Mohammad Banifazl3, Latif Gachkar4,

Sara Jam2, Ali Eslamifar1,

Farhad Yaghmaie5, Kambiz Nemati6,

Arezoo Aghakhani1

Iranian Journal of Pathology

2007

(2007)2

(4),

154

-158

87 ultrastructural evidences of growth inhibitory effects of a

novel biocide, Akacid(plus), on an aflatoxigenic

Aspergillus parasiticus.

Razzaghi-Abyaneh M, Shams-

Ghahfarokhi M, Kawachi M,

A, Schmidt OJ, Eslamifar

Schmidt A, Allameh A,

Yoshinari

Toxicon. ISI

2006

15;4

8(8

):1075

-82.

88 Cytosine deaminase producing Clostridium may be used in

detection of tumors.

Tirandaz H, Salehi-Najafabadi

EslamifarA, Med Hypotheses. ISI

2006

67(5

):1257

-8

89 Inhibitory effects of Akacid (plus) on growth and aflatoxin

production by Aspergillus parasiticus.

Razzaghi-Abyaneh M, Shams-

A, EslamifarGhahfarokhi M,

Schmidt OJ, Gharebaghi R,

Karimian M, Naseri A, Sheikhi

M.

Mycopathologia ISI

2006

Apr;

161(4

):245

-9

Page 22: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

22

90 Amygdala adenosine A1 receptors have no anticonvulsant

effect on piriform cortex-kindled seizures in rat.

Shahabi P, Mirnajafi-Zadeh J,

Fathollahi Y, Hoseinmardi N,

A. far-EslamiRezvani ME,

Can J Physiol Pharmacol ISI

2006

Aug-S

ep;8

4(8

-9):

913

-21.

91 Antiepileptogenic and anticonvulsant activity of

interleukin-1 beta in amygdala-kindled rats.

Sayyah M, Beheshti S,

A, far-EslamiShokrgozar MA,

Deljoo Z, Khabiri AR, Haeri

Rohani A.

Exp Neurol ISI

2005

Jan;1

91(1

):145

-53.

1 Occult HCV infection in hemodialysis patients with

elevated liver enzymes

Ramezani A, Eslamifar A

, Banifazl M2, Keyvani H,

Razeghi E, Ahmadi F, Amini M, Gachkar

L, Bavand AAghakhani

Arak Medical University Journal ISC

1392

201 4

, 16 -

80

34-4

0

2

Study on the Role of Alternaria alternata in the Etiology of

Allergic Asthma in Patients Admitted to Loghman

Hospital by using the Skin Prick Test and Solid-phase

Immunoassay

Fardis Teifoori , Masoomeh Shams-

Ghahfarokhi , Ali Eslamifar ,

Maryamossadat Moinazad-Tehrani ,

Parisa Mashayekhi , Mehdi Razzaghi-

Abyaneh

Modarres Journal of Medical Sciences

ISC

1392

16(2

) : 1-

12

3 Interleukin-10 Gene Promoter Polymorphisms and

Hepatitis B Virus Infection Outcome

Kalantar E, Ramezani A , Hosseini S,

Aghakhani A, Zarin Far N, Banifazl M ,

Deiry G, Roeei A, Ariamand A, Gachkar

L, Eslamifar A, and Sofian M

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1391

1680-0

192

4 Seroepidemiology of Hepatitis E Virus Infection in HIV

Infected Patients

Eslamifar A, Aghakhani A, Mohraz

M,Banifazl M, Foroughi M, Sharif MR

,Ansari F, Bolandghamat Z, and

Ramezani A

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1391

17, 5

9, 3

3-

36

Page 23: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

23

5

Epidemiological characteristics of animal bite cases

referred to treatment, rabies Pasteur Institute of Iran and

compare them in the 3-1372 and 8-1387 in Tehran.

Ahmad Fayaz, Vida Fallahiyan, Ali

Eslamifar

Medical research Journal

ISC

1390

35, 3

, 161

6 Frequency of Occult Hepatitis B Virus Infection in

Injection Drug Users

Ramezani A, Azadmanesh K, Aghakhani

A, Banifazl M, Farazi AA, Eslamifar A,

Edalat R, Izadi NA, Mahdaviani F and

Sofian M

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1389

15, 4

8. 1

7

7 Involvement of Human Papillomavirus Infection in

Prostate Carcinoma

Hamkar R, Parvin M, Ghavami N,

Ramezani A, Nadri M, Banifazl M,

Pakfetrat A, Eslamifar A and Aghakhani

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1389

15, 4

8. 1

7

8

Protozoa Cryptosporidium proliferation in Balb / c mice

and C76bl / 6 with suppressed immune Modeling of

Cryptosporidiosis in Immunodeficiency

sein Nahrevanian, Leila Abedinzadeh,

Karamollah Ghasemi, Ali Eslamifar,

Soheila Ajdari, Behzad Esfandiari,

Sadegh Rahbari, Marzieh Ezzati

Mirhashemi

Research Journal ISC

1389

15, 1

, 73

9 Seroprevalence of Bordetella Pertussis Antibodies in

Different Age Groups

Eslamifar A, Aghakhani A, Banifazl M,

Gachkar L, Khadem-Sadegh A,

Ramezani A

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1389

15, 4

9, 1

7

10 Subtype Mutations and Related Drug-Resistance in Anti-

Retroviral Treated HIV Infected Patients

Ramezani A*, Hamkar R, Aghakhani A,

Lorestani SH, Banifazl M, Truong HH,

McFarland W, Foroughi M, Eslamifar A

and Mohraz M

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1389

15, 5

0, 2

2

11 The prevalence of HHV-8 Kappes sarcoma in Iran by

Nested PCR

Zeinab osadat Nourozfar, Zahra Safai,

Amir Sohrabi, Afshin Moradi, Ali

Eslamifar

Nanotechnology Research microbial

Islamic Azad University

ISC

1389

2, 6

, 25

Page 24: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

24

12 Genetic variability of the S gene of hepatitis B virus

among High Risk Patients with Occult HBV Infection

Ramezani A, Hamkar R, Soufian S,

Banifazl M, Izadi N, Ghavami N, Sofian

M, Nazem H, Nadri M, Ahmadi F,

Razeghi E, Eslamifar A, and Aghakhani

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1389

14, 4

7

13 Persistence of Anti-HBs Antibody in HBV Vaccinated

Children in a Low Endemic Area for HBV

Nabiallah Izadi NA, Arezoo Aghakhani

A, Mohammad Banifazl M, Masoomeh

Sofian M, Fatemeh sadat Mahdaviani F,

Ali Eslamifar A , Akbar Khadem-

Sadegh A, and Amitis Ramezani A

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1389

14, 4

7

14 Association of Polymorphism of HLA-DRB1*13 and

HLA-A*33 Alleles with Outcome of Hepatitis B Virus

Infection

Velayati AA, Aghakhani A, Banifazl M,

, Khademi Z Eslamifar AKalantar E,

and Ramezani A

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1388

14, 4

6

15 Seroepidemiology of Hepatitis A Virus in Children

Residing in Tehran

Ramezani A, Sofian M, Banifazl M,

Farazi AA, Etemadi G, Azad-Armaki S,

, Eslamifar A,Ziazarifi AH, Abhari Z

Gachkar L, Khadem-Sadegh A and

Aghakhani A

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1388

14, 4

6

16 Isolated Anti-HBc in HIV- HCV Co-infected Patients Ramezani A, Aghakhani A, Banifazl M,

Eslamifar A, Mohraz M

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1388

14, 4

5

17 Prevalence of Hepatitis G Virus in the Sera of HIV

Infected Patients with Parenteral and Sexual Exposure , Eslamifar ARamezani A, Banifazl M,

Gachkar L, Aghakhani A

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1388

14, 4

5

18 Occult Hepatitis B Virus Infection among Blood Donors in

Arak

Masoomeh Sofian, Nabiallah Izadi,

Arezoo Aghakhani, Mohammad

Ali Banifazl, Ebrahim Kalantar,

Amitis Ramezani and Eslamifar

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1388

14, 4

5

Page 25: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

25

19 Occult hepatitis B virus infection in hemodialysis patients

amezani A, Banifazl M, Kalantar E,

, Eslamifar AAhmadi F, Razeghi E,

Atabak SH, Amini M, Gachkar L,

Khadem-Sadegh A, and Aghakhani A

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1388

14, 4

5

20 Making nanocomposite chitosan / polyvinyl alcohol

carbon nanotubes to nerve regeneration

Fatemeh Mottaghitalab2 ; Vahid

Ali ; 1Mehdi Farrokhi; 3Mottaghitalab

Mohammad Ali Shokrgozar 4slamifarE

MODARES

JOURNAL OF

MEDICAL

SCIENCES

(PATHOBIOLO

GY)

ISC

1388

12, 4

, 59

21 valuation of chitosan/poly (vinyl alcohol) nano-composite

biocompatibility for neural cells proliferation

Mohammad Ali Shokrgozar 1Fatemeh

Mottaghitalab2 ; Vahid Mottaghitalab3 ; 4

Ali Eslamifar; 1Mehdi Farrokhi

Pathobiology Research

ISC

1388

Volu

me

12, Issu

e 3

22 Occult Hepatitis B Virus Infection in HIV Infected

Patients

Ramezani A, Rasoolinejad M, Banifazl

, Gachkar Eslamifar AM, Aghakhani A,

L, and Mohraz M

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1387

13, 4

6

23 Asymptomatic Proteinuria in HIV-Infected Outpatients Aghakhani A, Mohraz M, Banifazl M,

, Gachkar L, Nemati Eslamifar AJam S,

K and Ramezani A

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1387

13, 4

2, 9

24 Hepatitis B Virus Genotype in Iranian Hepatocellular

Carcinoma patients

Hamkar R , Zamani N, Ramezani A,

, Banifazl M, Sofian M, Eslamifar A

Adibi L, saadat AR , Irani N, Mehryar M,

Taeb J, Deljoodokht Z, and Aghakhani A

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1387

13, 4

1, 2

2

Page 26: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

26

25 Prevalence and Genotype of Hepatitis G virus infection in

HIV Positive Patients

Ramezani A, Hekmat S, Jam S,

Vahabpour R, Bahramali G, Aghakhani

, Banifazl M, Gachkar L, Eslamifar AA,

anMohraz M

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1387

13, 4

1. 7

26 Blood Gamma Interferon Assay for Detection of Latent

Tuberculosis Infection: Potential to Replace the Mantoux

Skin Test

Kariminia A, Sharifnia Z, Aghakhani A,

, Deljoodokht Eslamifar ABanifazl M,

Z, Hazrati M, and Ramezani A

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1387

13, 4

0, 1

27 Long-Term Immunity of Hepatitis B Vaccine in Patients

Undergoin Hemodialysis

, , Eslamifar ARamezani A, Aghakhani A

Banifazl M, Gachkar L, Taeb J, Deljoo Z,

Kalantar E, and Velayati AA

Iranian Journal of Infectious Diseases

and Tropical Medicine ISC

1387

13,4

0,2

1

28 Reducing proteinuria resulting from ischemia - reperfusion

by a selective inhibitor of nitric oxide synthase in rat

kidneys

Maryam Zahmatkesh, Mehdi kadkhodai,

ali EslamifarFereshteh Golab,

Infectious Diseases and Tropical Medicine

Journal ISC

1387

2.3

7

29 Blood mercury levels in infants receiving vaccines

containing Thimerosal. Aghakhani A, Eslamifar A,Ramezani A,

Infectious Diseases and Tropical Medicine

Journal ISC

1386

12(3

8):1

7-

20

30 Eosinophilic gastroenteritis: A case report Aghakhani Eslamifar A,Soofian M,….

A, Ramezani A.

Infectious Diseases and Tropical Medicine

Journal ISC

1386

12(3

8):6

3-

6

Page 27: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

27

31 Natural YMDD mutants in chronic B hepatitis. . Eslamifar ARamezani A, Aghakhani A

Infectious Diseases and Tropical Medicine

Journal ISC

1386

12(3

7): 1

-6

32 Prevalence of Hepatitis G virus exposure in blood donors. Eslamifar ARamezani A, Gachkar L,

Infectious Diseases and Tropical Medicine

Journal ISC

1386

37(1

2).

33

The role of galanin receptors in antiن

convulsant effect of low frequency

stimulations on acquisition of perfor

ant path kindled seizures in rats

Mehdi Sadegh, Javad Mirnajafi-

Zadeh,Mohammad Javan, Yaghoub

Fathollahi, ohammad Mohammad-Zadeh,

li Jahanshahi, Ali Eslamifar, Zahra Deljo

Physiology and

Pharmacology

ISC

1386

11(1

), 10 - 1

8

34 Determination of Human Papillomavirus genotypes in

cervical cancer speciemens in Yazd province Mahmoodi SMM, Hamkar R,

Eslamifar A…

Infectious Diseases and Tropical Medicine

Journal ISC

1385

37(1

2)(

35 Detection of Hepatitis G Virus Envelope Protein E2

Antibody in Dialysis Staff

., Aghakhani A., Ramezani Eslamifar A

A., Hamkar R., Ahmadi F., Gachkar L.,

Atabak SH., Khameneh A., Ghadimi R.

and Velayati A.A

Infectious Diseases and Tropical Medicine

Journal ISC

1385

11,3

5

36 Demonstration of microbial biofilm in Ethmoidal sinus of

refractory chronic rhinosinusitis patients by SEM Eslamifar Adi Y, Naraghi M, Ami

The Iranian journal of Otorhinolaryngology ISC

1385

18(4

6):1

81

-4

37

Detection of High Risk Human Papillomaviruses in

Esophageal Squamous Cell Carcinoma by PCR and DNA

Sequencing.

., Aghakhani A. , Hamkar Eslamifar A

R., Ramezani A., Tirgari F., Frootan H.,

Mirmomen Sh., Gheini MH. ,

Deljoodookht Z., Taeb J

Infectious Diseases and Tropical Medicine

Journal ISC

1384

11(3

3): 1

-5

Page 28: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

28

38 Detection of Hepatitis G Virus Envelope Protein E2

Antibody in Dialysis Staff ni A., Aghakhani A. RamezaEslamifar A

Infectious Diseases and Tropical Medicine

Journal ISC

1384

11(3

5): 7

3-

79

39 Molecular epidemiology of clinical strains of enteococci

Faecium in Tehran hospitals

Ramezani A, Mohraz M, Feizabadi M,

Eslamifar Asgharzadeh A, Parastan R,

elayati AAliahmadi A, V A,

Infectious Diseases and Tropical Medicine

Journal ISC

1383

Vol. 1

0,

No. 3

1

40 Influence of electrical destruction of Amygdal on

convulsion due to , Eslamifar AShahabi P, Mirnajafi J,

Deljoo Z.

Physiology and Pharmacology Journal ISC

1383

Vol. 9

, No.

2

41 Study Epidemiology of animal bites in persons referred to

Institute Pasteur of Iran (Tehran province). , Nazgooie F,, Eslamifar ARamezani A

Falahian L, Hazrati M, Naseri M.R.

Infectious Diseases and Tropical Medicine

Journal ISC

1382

Vol. 9

, No.

27

42

Study vaccine includes thiomersal and relations with

neurodevelopment disorders in neonates and embryonic

periods.

Hazrati M. Eslamifar A,Ramezani A, Infectious Diseases

and Tropical Medicine Journal

ISC

1382

Vol. 9

, No.

26.

43 Epidemiology of animal rabies in Tehran province. A, Eslami N, A, EslamifarRamezani Nazgooie F.

Infectious Diseases and Tropical Medicine

Journal ISC

1382

Vol. 9

, No.

25

44 Survey situation of nosocomial infection due to enterococci in Tehran hospitals.

amezani A, Mohraz M, Asadi S, Eslamifar A.Nazgooie F,

Infectious Diseases and Tropical Medicine

Journal ISC

1381

19, 1

1

Page 29: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

29

Seminars and academic conferences

Cod

Title Authors conferences Year Place

1 Using Confocal microscopy in clinical research Ali Eslamifar, Saeid Mahmoudi

The 2 nd congress of Cytotechnology

And Its Applications

2015 Iran

2 Molecular epidemiology of human parvovirus B19 in a cohort of

HIV-infected patients

Amitis Ramezani, Kayhan

Azadmanesh Kazemimanesh, M

A Foroghi,, Mohammad Banifazl,

Arezoo Aghakhani, M ,arEslamif

Mohraz

ESCMID 2015 Denmark

3 No evidence of occult hepatitis C virus infection among renal

transplant candidates

A. Eslamifar, A. Ramezani

S. Ossareh, M. Banifazl, H.

Keyvani, A. Aghakhani

ESCMID 2015 Denmark

4 Interleukine-17 and TGF-beta levels in patients with acute

brucellosis and its relation with treatment

M. Sofian, A. Ramezani*M.

Banifazl, A. Eslamifar, S. Cherei,

A. Cherei, A. Aghakhani

ESCMID 2015 Denmark

5 BK viraemia in patients with chronic renal disease undergoing

haemodialysis and peritoneal dialysis

A.Ramezani*A. Sharif, M.R.

Sharif, A. Aghakhani, R. Hamkar,

N. Ghavami, A. Eslamifar, M.

Banifaz

ESCMID 2015 Denmark

6 Occult hepatitis B virus infection in HIVinfected patients after

HBV vaccination

A. Ramezani* M. Mohraz,

Aghasadeghi, M. Banifazl, R.

Vahabpour, M. Foroughi, A.

Eslamifar, A. Aghakhani

ESCMID 2015 Denmark

7 Using confocal microscopy in the

diagnosis of pathology

Mahmoudi. saeidAli Eslamifar

Samaneh saffar nazanin sharifi .

mehrad eslamifar. mohsen

Congress of Pathology

2015 Iran

Page 30: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

30

8 Occult hepatitis C virus infection among Iranian haemodialysis

patients Amitis Ramezania Mohammad

Ali EslamifarBanifazlf hepatitis 2014 Iran

9 Seroepidemiology of Hepatitis E Virus infection in Blood Donors

of Central Province of Iran

Hassan Ehteram, Amitis Ramezani

, Masoomeh Sofian Ali Eslamifar

Mohammad Banifazl, Parisa

Mashayekhi 5, Arezoo Aghakhani

Congress of Pathology

2013 Iran

10 No Evidence of Human Papillomavirus Infection in the Etiology of

Colon Adenocarcinamas and Adenomas

Arezoo Aghakhani1, Rasool

, Farahnaz Ali EslamifarHamkar,

Bidari Zerehpoosh3

Shahram Sabeti3, Nastaran

Ghavami2, Mohammad Banifazl4,

Amitis Ramezani1

Congress of Pathology

2013 Iran

11 Hematological Reference Ranges for Healthy Adult Males in the

Central province of Iran

Masoomeh Sofian1, Mandana

Aghakhani3, Mohammad Banifazl

Nader Zarinfar , Ali Eslamifar

Fatemeh Mahdaviani, Ramezani3

Congress of Pathology

2013 Iran

12 Immunogenicity of one Intradermal or Intramuscular Booster

Vaccination Dose in HIV Infected individuals who failed to

Standard Vaccination

Masoomeh Sofian1, Alireza

Janbakhsh2, Aghakhani3*,

Banifazl4 Maryam Gol-

Ali Eslamifar3,Mohammadi5,

Mahdavian2

Congress of Pathology

2013 Iran

13 Immunity to Diphtheria and Tetanus among Blood Donors in a

Central Iranian City

1, Amitis Ramezani Ali Eslamifar

1, Mohammad Banifazl 2,

Masoomeh Sofian 3, Fatemeh-

Mahdaviani 4, Aghakhani

Congress of Pathology

2013 Iran

14 P931 Serum profile of T helper 1 and T helper 2 cytokines in

HCV-infected patients

Arezoo Aghakhani,1 Mohammad

Banifazl,2 Ali Akbar Velayati,3

,1 and Amitis Ali Eslamifar

Ramezani

ESCMID 2012 England

15 R2406 Reduction in interleukin-2 serum levels but lack of

evidence of the Th1 to Th2 cytokine shift during the course of HIV

infection

afyeh Soufian · Amitis Ramezani ·

Aghakhani · Mohammad Banifazl ·

· Minoo Mohraz Ali Eslamifar ESCMID 2012 England

Page 31: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

31

16 PP-045 Pathophysiology of cryptosporidiosis in

immunosuppressed Balb/c and C57bl/6 mice models

H. Nahrevanian, L. Abedinzadeh,

M. Amini, S. Eslamifar,A.

Naeimi 5 th DICID 2011 China

17 Follow up Hemodialysis Patients with Occult Hepatitis B Virus

Infection

, Ali EslamifarAmitis Ramezani,

Mohamad banifazel, Farrokhlagha

Ahmadi

iiccom 2013 Iran

18 Frequency of hepatitis D Virus Infection in HIV positive and

hemodiyalisis patients in Iran

Amitis Ramezani, Mohammad reza

Aghasadeghi, golnaz bahramali,

Arezoo Aghkhani, Mohammad

banifazl, Seyed Mehdi Sadat,

, Ali EslamifarMaryam Foroghi,

Seyed davar Siadat

iiccom 2011 Iran

19 Comparison of Brucella Induced epididymo or orchitis, with

Nonspecific Area for Brucellosis

Masomeh Sofiyan, Amitis

Ramezani, Arezoo Aghkhani,

Ali Mohammad banifazl,

Hossein Sarmadian, Ali Eslamifar,

akbar velayati

iiccom 2011 Iran

20 Tetanus and Diphtheria seroprevalence in HIV Infected patients

, Amitis Ramezani, Ali Eslamifar

Minoo Mohraz, Mohammad

banifazl, Maryam Foroghi Arezoo

Aghkhani,

iiccom 2011 Iran

21 Eroprevalence of human T-Cell Leukemia Virus Type 1 (HTLV-1)

and HTLV-2 Infection in HIV Infected patients

Amitis Ramezani, Arezoo

Aghkhani, Mohammad banifazl,

Ali Eslamifar,Maryam Foroghi,

Minoo Mohraz,

iiccom 2011 Iran

22 Serum Profile of T helper 1 and T helper 2 Cytokines in HCV

Infected patients

Amitis Ramezani, Masomeh Sofian

Arezoo Aghkhani, Ali Asghar

Ali Farazi Mohammad banifazl,

Ali Akbar Velayati Eslamifar,

iiccom 2011 Iran

23 Occult Hepatitis B Virus Infection in Hemodialysis Patients

Arezoo Aghkhani, Mohammad

Reza Aghasadeghi, Mohammad

Shahin Ali Eslamifar,banifazl,

ghasemi, Farrokhlagha Ahmadi

Amitis Ramezani, Ali

iiccom 2013 Iran

Page 32: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

32

24 Seroprevalence of Brucellosis Antibodies in blood Donors in

Central Province of Iran

Masomeh Sofiyan, Mehrnoosh

Sheikholeslami, Hossein

Sarmadian, Fatemeh Alsadat

Ali Mahdaviani, Arezoo Aghkhani,

orban Deiri Amitis Gh Eslamifar,

Ramezani,

iiccom 2013 Iran

25 prevalence of HIV, HCV and HBV Infections and Associated Risk

Factors among Injecting Drug User in Arak City

Masomeh Sofiyan, Arezoo

Aghkhani,Reyhaneh Amir Moezzi,

Nader Zarinfar, Mohammad

Amitis lamifarAli Esbanifazl,

Ramezani,

iiccom 2013 Iran

26 Importance of Family Members Screening of Cases with Acute

Brucellosis

Masomeh Sofiyan, Leila

Safaeipour, Arezoo Aghkhani,

Ali Mohammad banifazl ,

Ali Asghar Farazi, Eslamifar

Farshideh didgar,

iiccom 2013 Iran

27 Hepatitis E Virus co-Infection in HIV Infected patients

Amitis Ramezani Minoo Mohraz,

Mohammad Ali Eslamifar

banifazl ,Sara khorrami, Masomeh

Sofiyan, Arezoo Aghkhani

iiccom 2013 Iran

28 Mutations in the S gene region of hepatitis B virus in High Risk

Patients with Occult HBV Infection

Ramezani A, Aghakhani A,

and Eslamifar ASoufian S,

Banifazl M 20th ECCMID 2010 Australia

29 Distribution of pertussis antibodies among Iranian children of

different age groups.

A, Aghakhani A, Eslamifar

Banifazl M, Khadem-Sadegh A

and Ramezani A. 20th ECCMID 2010 Australia

30 The Role of Human Papillomavirus Infection in Prostate

Carcinoma

Aghakhani A, Hamkar R, Parvin

A, Banifazl M and EslamifarM,

Ramezani 14th ICID 2010 America

31 Frequency of isolated antibody to hepatitis B core antigen in HIV-

HCV coinfected individuals Ramezani A, Aghakhani A,

A, Banifazl M. Eslamifar 14th ICID 2010 America

Page 33: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

33

32 Association of polymorphism of HLA-DRB1 13 and HLA-A 33

alleles with outcome of hepatitis B virus infection. Ramezani A, Aghakhani A,

A, Banifazl Eslamifar 14th ICID 2010 America

33 No evidence of occult hepatitis B virus infection among anti-HBc-

positive blood donors in an area of low endemicity for HBV Ramezani A, ,Aghakhani A,

A, Banifazl M Eslamifar 14th ICID 2010 America

34 Frequency of occult hepatitis B virus infection in HIV infected

patients Ramezani A, Aghakhani A,

A, Banifazl M Eslamifar 14th ICID 2010 America

35 The epidemiology of tuberculosis in Arak city, Central province of

Iran from 1997- 2007 Ramezani A, Aghakhani A,

A, Banifazl M Eslamifar 14th ICID 2010 America

36 nti-HBs titers in vaccinated children and adolescents: Implication

for booster administration. Ramezani A, Aghakhani A,

A, Banifazl Eslamifar 14th ICID 2010 America

37 Prevalence of Occult Hepatitis B Infection in Iranian Injection

Drug Users Ramezani A, Banifazl M,

A, Aghakhani A Eslamifar 14th ICID 2010 America

38 Association of Human Papillomavirus and Breast Carcinoma. A, Ramezani A, Eslamifar

Banifazl M, Bidari F, Moradi A

and Aghakhani A.

19th Iranian

congress on

infectious diseases

and tropical

medicine

2010 Iran

39 Occult and chronic hepatitis B, hepatitis C, and HIV infections and

co-infections among injection drug users. Ramezani A, Sofian M, Aghakhani

.A, Banifazl M EslamifarA,

19th Iranian

congress on

infectious diseases

and tropical

medicine

2010 Iran

Page 34: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

34

40 Genotype characterization of hepatitis G virus isolates from Iranian

patients infected with human immunodeficiency virus. Ramezani A, Mohraz M,

A, EslamifarAghakhani A, 19th ECCMID 2009 Finland

41 Occult hepatitis B virus infection in ―anti-HBc alone‖

haemodialysis patients.

Ramezani A, Aghakhani A,

Mohraz M, Eslamifar A, Khadem-

Sadegh A,

Banifazl M.

19th ECCMID 2009 Finland

42 Predictive value of purified protein derivative in pulmonary

tuberculosis in a high BCG-vaccinated population

Sofian M, Ramezani A, Aghakhani

A, Eshrati B, Eslamifar A,

Banifazl 19th ECCMID 2009 Finland

43 Identification of hepatitis B virus genotype in patients with

hepatocellular carcinoma in Iran. Aghakhani A, Hamkar R,

Eslamifar ARamezani A 19th ECCMID 2009 Finland

44 Significance of Hepatitis B Core Antibody as the Only Marker of

Hepatitis B Virus Infection. Ramezani A, Mohraz M, Banifazl

M, Eslamifar A and Aghakhani

The 3rd Annual

Iranian Congress

on HIV/AIDS

2009 Iran

45 Frequency of isolated antibody to hepatitis B core antigen in

HIV- HCV coinfected individuals

Aghakhani A, Mohraz M, Banifazl

M, Eslamifar A, Khadem-Sadegh

A and

Ramezani A

The 3rd Annual

Iranian Congress

on HIV/AIDS

2009 Iran

46 Frequency of Occult Hepatitis B Virus Infection and its Surface

Mutants in HIV Positive Patients

Ramezani A, Mohraz M,

Aghakhani A, Banifazl M,

Eslamifar A Hamkar

The 3rd Annual

Iranian Congress

on HIV/AIDS

2009 Iran

47 Occult hepatitis B virus infection in blood donors with isolated

anti-HBc

Ramezani A, Sofian M, Aghakhani

A, Eslamifar A, Izadi N, Banifazl

M.

18th

Iranian congress on

infectious diseases

and tropical

medicine

2009 Iran

48 Association of Human Papillomavirus with Prostate Cancer Aghakhani A, Hamkar R, Parvin

M, Eslamifar A, Banifazl M,

Ramezani A

18th Iranian

congress on

infectious diseases

2009 Iran

Page 35: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

35

and tropical

medicine,

49 Seroepidemiology of pertussis antibodies among children of

different age groups.

Eslamifar A, Aghakhani A,

Banifazl M, Khadem-Sadegh A,

Ramezani A

18th Iranian

congress on

infectious diseases

and tropical

medicine

2009 Iran

50 Hepatitis B virus Surface Gene Mutations in High Risk Patients

with Occult HBV Infection

Ramezani A, Mohraz M, Hamkar

R, Aghakhani A, Eslamifar A,

Soufian S,

Banifazl M

18th Iranian

congress on

infectious diseases

and tropical

medicine

2009 Iran

51 Age specific seroprevalence of hepatitis A antibody: Implications

for health policy.

Ramezani A, Aghakhani A,

Eslamifar A, Khadem-Sadegh A,

Banifazl M.

18th Iranian

congress on

infectious diseases

and tropical

medicine

2009 Iran

52 Seroprevalence of hepatitis B surface antibody in children

subjected to the Expanded Programme on Immunization (EPI).

Ramezani A, Aghakhani A,

Eslamifar A, Khadem-Sadegh A,

Banifazl M.

18th Iranian

congress on

infectious diseases

and tropical

medicine

2009 Iran

53 Hepatitis G virus infection in patientsinfected with the human

immunodeficiency virus

Ramezani A, Mohraz M,

Vahabpour R, Eslamifar A,

Mahboudi F,

Aghakhani A, Edalat R, Hekmat S

13th ICID 2008 Malaysia

54 Association between HLA-A, B, DRB1 alleles and susceptibility

or resistance to chronic hepatitis B Ramezani A, Eslamifar ATaeb J,

Aghakhani A 13th ICID 2008 Malaysia

Page 36: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

36

55 Prevalence of Metabolic abnormalities in HIV-Infected Patients

Receiving Highly Active Antiretroviral Therapy and antiretroviral-

naive patients

Ramezani A, Mohraz MAghakhani

A, Eslamifar A 13th ICID 2008 Malaysia

56 Long term Immune response to hepatitis B vaccine in hemodialysis

patients Ramezani A, Eslamifar A, Mohraz

M,….. and Aghakhani 13th ICID 2008 Malaysia

57 Comparison of IFNgamma assay and Tuberculin Skin Test for

detecting latent tuberculosis infection in BCG-vaccinated

population.

Ramezani AEslamifar Aghakhani

A. 13th ICID 2008 Malaysia

58 The role of fungi in the etiology of chronic rhinosinusitis Eslamifar A, Aghakhani A

,Ramezani A

12th International

Congress of

Mycology

2008 Turkey

59 Genotype Characterization of Hepatitis B Virus Isolates from

Iranian Patients with Hepatocellular Carcinoma . Aghakhani A, Hamkar REslamifar

ARamezani A.

10th annual

congress of

pathology and 4th

annual

congress of Iranian

cancer association,

2008 Iran

60 Frequency of Fungi and Eosinophilic Granulocytes in Chronic

Rhinosinusitis . Eslamifar ARamezani Aghakhani

A

10th annual

congress of

pathology and 4th

annual

congress of Iranian

cancer association,

2008 Iran

61 Significance of Hepatitis B Core Antibody as the Only Marker of

Hepatitis B Virus Infection Ramezani A, Mohraz M, Banifazl

M, Eslamifar A and Aghakhani

17th Iranian

congress on

infectious diseases

and tropical

medicine

2008 Iran

Page 37: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

37

62 Genotype characterization of hepatitis G virus isolates from Iranian

patients infected with human immunodeficiency virus (HIV). Ramezani A, Mohraz MAghakhani

AEslamifar A and Velayati

17th Iranian

congress on

infectious diseases

and tropical

medicine

2008 Iran

63 Frequency of isolated antibody to hepatitis B core antigen in HIV-

HCV coinfected individuals

Ramezani A, Mohraz M,

Aghakhani A, Banifazl M,

Eslamifar, Khadem-

Sadegh A, Velayati AA

17th Iranian

congress on

infectious diseases

and tropical

medicine

2008 Iran

64 Association of polymorphism of HLA-DRB1*13 and HLA-A *33

alleles with outcome of hepatitis B virus infection. Ramezani A, Aghakhani

AEslamifar A

17th Iranian

congress on

infectious diseases

and tropical

medicine

2008 Iran

65 Frequency of occult hepatitis B virus infection in HIV infected

patients.

Ramezani A, Mohraz M,

Aghakhani A, Banifazl M,

Eslamifar A, Velayati

17th Iranian

congress on

infectious diseases

and tropical

medicine

2008 Iran

66 Occult hepatitis B virus infection in "anti-HBc alone" hemodialysis

patients.

Ramezani A, Aghakhani A,

Eslamifar, Khadem-Sadegh A,

Banifazl M.

17th Iranian

congress on

infectious diseases

and tropical

medicine

2008 Iran

67 Risk factors for human brucellosis in Iran: a case control study. M. Soofian, A. Ramezani, A.

Aghakhani, A. Eslamifar ECCMID-ICC 2007 Germany

Page 38: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

38

68 Prevalence of hepatitis G exposure in patients on chronic dialysis. Eslamifar A. ,Aghakhani A.

,Ramezani A

1st European

Congress of

Pathology

2007 Turkey

69 Performance of QuantiFERON TB-G Test for detecting latent

tuberculosis infection in BCG-vaccinated population.

A. Kariminia, Z. sharifnia, A.

Aghakhani, M. Banifazl , A.

Eslamifar,

M.Hazrati and A. Ramezani.

16th

Iranian congress on

infectious diseases

and tropical

medicine

2007 Iran

70 Persistence of Hepatitis B Vaccine Immunity in Hemodialysis

Patients A.Ramezani, A.Eslamifar......

A.Aghakhani.

16th Iranian

congress on

infectious diseases

and tropical

medicine

2007 Iran

71 Frequency of hepatitis B and hepatitis C virus infections in HIV

infected subjects A.Ramezani,M.Mohraz,....A.Agha

khani,.Eslamifar

16th Iranian

congress on

infectious diseases

and tropical

medicine

2007 Iran

72 Impact of antiretroviral treatment on lipid profile in HIV infected

patients A.Ramezani,M.Mohraz,....A.Agha

khani,.Eslamifar,

16th Iranian

congress on

infectious diseases

and tropical

medicine

2007 Iran

73 Anemia in HIVinfected patients receiving highly active

antiretroviral therapy A.Ramezani,M.Mohraz,....A.Agha

khani,.Eslamifar,.

16th Iranian

congress on

infectious diseases

and tropical

medicine

2007 Iran

Page 39: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

39

74 Influence of HLA class І and II alleles on the outcome of hepatitis

B virus infection.

A.Ramezani.MR Hasanjani

Roshan,...A.Eslamifar, Taeb, A.

Aghakhani

16th Iranian

congress on

infectious diseases

and tropical

medicine

2007 Iran

75 Detection of YMDD mutation in Iranian chronic hepatitis B

patients before lamivudine treatment. A.RamezaniA.Eslamifar and A.

Aghakhani.

9th annual congress

of pathology and

3rd annual

congress of Iranian

cancer

association

2007 Iran

76 Frequency of Human Papillomavirus Infection in Esophageal

Squamous Cell Carcinoma of Iranian patients. Esalamifar A, Aghakhani A,

Hamkar R, Ramezani

12th International

Congress on

Infectious

Diseases,

2006 France

77 Hepatitis G virus exposure in dialysis patients. Eslamifar A, Ramezani A....

Aghakhani

8th annual congress

of pathology and

2nd congress of

oncology

2006 Iran

78 Role of human papillomavirus infection in esophageal carcinoma Eslamifar A , Hamkar R,

Ramezani A.... Aghakhani A.

8th annual congress

of pathology and

2nd congress of

oncology

2006 Iran

79 Epidemiology of Animal Bites in Tehran. Eslamifar A, Aghakhani A,

Ramezani A,

15th Iranian

congress on

infectious diseases

and tropical

medicine

2006 Iran

Page 40: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

40

80 Hepatitis G virus(HGV) Exposure in Dialysis Staff Eslamifar A, Hamkar R,

Ramezani … Aghakhani

15th Iranian

congress on

infectious diseases

and tropical

medicine

2006 Iran

81 YMDD mutants in patients with chronic hepatitis B before

treatment are not selected by lamivudine. Ramezani A , Eslamifar A and

Aghakhani

15th Iranian

congress on

infectious diseases

and tropical

medicine

2006 Iran

82 Exposure to Hepatitis GB Virus in Patients on Maintenance

Hemodialysis. Eslamifar A, Hamkar R,

Ramezani … Aghakhani

15th Iranian

congress on

infectious diseases

and tropical

medicine

2006 Iran

83 Factors influencuing to hepatitis B virus vaccination in

hemodialysis patiens. Ramezani , Eslamifar A

XLIII ERA-EDTA

Congres 2006 England

84 Frequency of Hepatitis G infection among Iranian blood donors Ramezani A, Eslamifar A

12th international

congress on

infectious diseases

2006 Portugal

85 Assesment of blood mercury levels in infants exposed to vaccines

containing thiomersal Ramezani,Eslamifar A

2nd international

congress on

infectious and

tropical diseases

2006 Amman

86 Efficacy of hepatitis B vaccination schedule and comparing to

complete regimen hemodialysis patients of Iran Ramezani, Eslamifar A

12th

international

congress on

infectious diseases

2006 Portugal

Page 41: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

41

87 Frequency of hepatitis G infection among Iranian blood donors Gachkar L, Ramezani A,

Eslamifar A, Hamkar R,

Khoshbaten M, Hazrati

14th Congress

of Infectious

Disease

2005 Iran

88 Frequency of vancomycin resistant Enterococci faecium in

hospitals of Tehran.

Ramezani A, Mohraz M, Feiabadi

M, Banifazl M, Eslamifar A,

Velayati

14th Congress

of Infectious

Disease

2005 Iran

89 Factors influencing to hepatitis B vaccination response in

hemodialysis patients of Tehran (Iran). Ramezani A, Eslamifar A, Hazrati

Mb, Mohraz M

14th Congress

of Infectious

Disease

2005 Iran

90 Case report of skull plasmocytic granulom and study Efficacy of

electron microscopy on diagnosis. Eslamifar A

Congress of

Pathology 2004 Iran

91 Rates of scar failure in children vaccinated with BCG A, Heidari EslamifarRamezani A,

L, Hosseini H, Hazrati M

13th Congress of

Infectious

Diseases.

2004 Iran

92 Situation of MR vaccination on mass campaign project in persons

referred to Pasteur Institute of Iran.

A, Ramezani A, Eslamifar

Nazgooie F,Mafakheri M, Hosseini

Z Naseri M.

12th Congress of

Infectious Diseases 2003 Iran

Page 42: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

42

Research projects:

Title

Cod

Prevalence of human papillomavirus infection in patients with breast cancer and benign breast samples referred to Shohada hospital, and Imam

Luqman 1

Restoring blanket making nanofibers carrier Antidermatophytal terbinafine and evaluation of in vitro 2

Prevalence of human papillomavirus infection in patients with adenocarcinoma of the colon and colorectal adenomatous polyps admitted to

hospital in Mashhad University of Medical Sciences 3

The effect of solid lipid nanoparticles containing the parasite Leishmania in vitro Paramomycin 4

An auto machine produces a variety of solutions hematology analyzers 5 Part 5

Effect Of Animal bites that have received post-exposure treatment, vaccination three times 6

The study of the expression of markers of immune response to Mycobacterium tuberculosis-specific antigen using pcr possible to distinguish

between active and latent forms of Mycobacterium tuberculosis 7

Page 43: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

43

Seroepidemiology of IgG antibodies against diphtheria and tetanus immune level of blood donors living in Arak 8

Quantiferon production of diagnostic kits for detecting active and latent TB infection 9

Production of 4-channel processor machine semi-automatic cytology. 10

Technical knowledge to design and produce the third generation kits based broth 11

Highly sensitive molecular detection kit 11

evaluate the role of PfGCS1 antibody in inhibiting the formation of ovokinet in Anopheles stephensi with the aim of developing a vaccine

against Plasmodium falciparum Transmission Blocking Vaccine 12

DNA evaluation and Live vaccines expressing MHC class I epitopes supply capacities in structure to protect against Lyshnanya major part in a

mouse model Balb / c 13

Page 44: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

44

Prevalence of hepatitis c virus latent infection in patients undergoing kidney transplant 14

Study of Latent infection and hepatitis B virus vaccine escape mutations in HIV infected patients vaccinated with hepatitis B vaccine 15

Seroepidemiological study of HBV infection and HBV vaccine strains escape mutant vaccine in individuals vaccinated with national

vaccination protocol 22 16

Seroconversion Study in Animal bites that have received post-exposure treatment, vaccination three times 17

Page 45: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

45

Patents

The names of colleagues Date Title of the invention Cod

Azar Tahghighi, Naser Naghdi, Ali

Eslamifar 1393

The synthesis of the intermediate raw material medicine Cetirizine

hydrochloride hydroxyzine and turn it into crystal form 1

Reza Shirkohi, Monir Salati, Ebrahim

Azizi, Mansour Abachi, Ali Eslamifar 1395

the same molecular personal 9 motation point associated with

thrombophilia with high sensitivity technology based on TaqMan

probe by PCR- Real Time 2

Theses

As the course By Direction Thesis title Cod

M.Sc. Mehdi

Alikhanipor Supervisor

Identify and assess the effects of some herbs on blood coagulation by

comoanformatic 1

M.Sc. Bahareh Soltan

Ahmadi Advisor

Molecular detection of papilloma virus that causes cervical cancer

genotypes in Tehran 2

Page 46: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

46

PhD Hassan Ebrahimi Advisor Evaluation of brain tumors in vivo in animal models using platinum

Nanvsys 3

M.Sc. Akbar Zahery Supervisor Risk assessment and provide a comprehensive program of HSE

management in the laboratory of Pasteur Institute of Iran, Tehran

specialized services 4

PhD Fardis Tifori Supervisor

Altal in Ltranya and sex-related gene review and evaluate the

allergenic proteins resulting in asthma and allergies in patients with

lower respiratory tract disorders.

5

PhD Elham Mohit Advisor

Construction and evaluation of DNA vaccine defiantly from two

perspectives prevention and treatment of HPV16 E7 gene using with

IP-10, GRP96

6

PhD Negar Seyed Advisor

Design and construction have made what looked like human epitopes

stimulating CD8 cells against Leishmania major, according to In

Silico prediction methods and immunogenicity in HLA transgenic

mice containing human

7

PhD Maryam Barzin Advisor Evaluation of the efficacy and short-term and long-term effects of

bariatric surgery in the treatment of patients with obesity 8

Page 47: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

47

Teaching Course

Date University As the course Title of course Cod

1384/1 Institute Pasteur of Iran PhD Electron microscopy course 1

1384/1 Institute Pasteur of Iran M.Sc. Electron microscopy course 2

1384/2 Institute Pasteur of Iran M.Sc. Electron microscopy course 3

1384/2 Institute Pasteur of Iran M.Sc. Electron microscopy course 4

1384/2 Institute Pasteur of Iran M.Sc. Electron microscopy course 5

1383/1 Institute Pasteur of Iran M.Sc. Pathology course 6

1383/2 Institute Pasteur of Iran PhD Electron microscopy course 7

1385/1 Institute Pasteur of Iran M.Sc. Electron microscopy course 8

1385/1 Institute Pasteur of Iran PhD Electron microscopy course 9

1385/2 Institute Pasteur of Iran M.Sc. Electron microscopy course 10

1385/2 Institute Pasteur of Iran PhD Electron microscopy course 11

Page 48: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

48

1386/1 Institute Pasteur of Iran PhD Electron microscopy course 12

1386/2 Institute Pasteur of Iran PhD Electron microscopy course 13

1387/1 Institute Pasteur of Iran PhD Electron microscopy course 14

1387/2 Institute Pasteur of Iran PhD Electron microscopy course 15

1387/2 Institute Pasteur of Iran PhD Electron microscopy course 16

1387/2 Institute Pasteur of Iran M.Sc. Electron microscopy course 17

1388/1 Institute Pasteur of Iran M.Sc. Electron microscopy course 18

1389/1 Institute Pasteur of Iran PhD Electron microscopy course 19

1390/1 Institute Pasteur of Iran PhD Electron microscopy course 20

1391/1 Institute Pasteur of Iran PhD Electron microscopy course 21

1392/1 Institute Pasteur of Iran PhD Electron microscopy course 22

1387/1 Institute Pasteur of Iran M.Sc. Pathology course 23

1388/1 Institute Pasteur of Iran M.Sc. Pathology course 24

Page 49: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

49

1390/1 Institute Pasteur of Iran M.Sc. Pathology course 25

1391/1 Institute Pasteur of Iran M.Sc. Pathology course 26

1392/1 Institute Pasteur of Iran M.Sc. Pathology course 27

1393/1 Institute Pasteur of Iran M.Sc. Pathology course 28

1394/1 Institute Pasteur of Iran M.Sc. Pathology course 29

Books

Cod Name of Books Publication Date

1 Application of Nanotechnology in Medicine Sharh 1384

2 Guide to antimicrobial therapy Iranian society for infectious diseases and

tropical medicine publicatio

1386, 1387,

1388, 1389

3 Nanotechnology and Medicine Hayyan 1388

4 Guide to antimicrobial therapy and vaccination Poshe 1390

5 Guide to antimicrobial therapy and vaccination Iranian society for infectious diseases and

tropical medicine publicatio 1391

Page 50: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

50

Membership

Cod Committee

1 Member of Iranian Society of Pathology

2 Member of Iranian Cancer Society

3 Member of Board in Iranian Physician Council

4 Member of Scientific Executive Committee of Iranian Infectious Diseases Conferences

5 Member of Specialized Committee on Research Projects

6 Member of Regional Committee on Ethics

7 Reviewer of Iranian journal of infectious disease and tropical medicin

Page 51: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

51

Workshops

Cod Name of Cours Date Place

1 Brucellosis Conference 1390 University of Medical Sciences

2 Congress Infectious Diseases and Tropical Medicine 1390 Association of Infectious Diseases and Tropical Medicine

3 Congress Infectious Diseases and Tropical Medicine 1390 Association of Infectious Diseases and Tropical Medicine

4 Third Symposium on Electronic and Telemedicine Hospital 1391 medical University Tehran

5 Congress Infectious Diseases and Tropical Medicine 1390 Association of Infectious Diseases and Tropical Medicine

6 Endocrine pathology program 1392 Association Pathology

7 Blood Bank Program 1392 Association Pathology

8 Microbiology program 1392 Association Pathology

9 Pathology Annual Meeting Iran 1392 Association Pathology

10 Balancing quality control program for clinical laboratories 1392 Medical Council of Islamic Republic of Iran

11 Congress Infectious Diseases and Tropical Medicine 1392 Association of Infectious Diseases and Tropical Medicine

12 Improving quality of services of education Laboratory 1392 Medical Council of Islamic Republic of Iran

13 Conference on biological changes in laboratory 1392 Medical Council of Islamic Republic of Iran

14 Communication between doctor and laboratory conferences 1392 Medical Council of Islamic Republic of Iran

Page 52: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

52

15 Laboratory status conference on health promotion and patient care 1392 Medical Council of Islamic Republic of Iran

16 Prvssyng workshop, Painting and histopathological examination of

samples sent to pathology labs 1393 Institute Pasteur of Iran

17 Workshop with Electron Microscope SEM 1393 Institute Pasteur of Iran

18 Practical workshops with flow cytometry BD Facscalibur 1393 Institute Pasteur of Iran

19 Seminar with the principles of quality management and internal

audit based on standard requirements 1393 Institute Pasteur of Iran

20 Pathology and Laboratory Medicine Annual Meeting 1393 Association of Infectious Diseases and Tropical Medicine

21 The macroeconomic 1394 Institute Pasteur of Iran

22 Biorisk Management Workshop 1394 Institute Pasteur of Iran

23 Workshop knowledge-based companies 1394 Institute Pasteur of Iran

24 And lead auditor training course documentation and auditing of ISO

/ IEC 1392 ISIRI

25 Future workshops vaccines and drugs industry and economy 1393 Institute Pasteur of Iran

26 Workshop sample management and secure transport

And safety 1392 Reference Laboratory Ministry of Health

27 DNA sequencing 1394 Institute Pasteur of Iran

Page 53: Curriculum Vitae Dr. Ali Eslamifar

Curriculum Vitae Dr. Ali Eslamifar

53

28 Confocal microscopy and its applications 1394 Institute Pasteur of Iran

29 Audit Office in collaboration with Middle East TUV.UK & I 1394 Institute Pasteur of Iran

30 Understanding and working with electron microscopy, SEM 1392 Institute Pasteur of Iran

31 Internal audit followed standard requirements ISIRI-ISO 1393 Institute Pasteur of Iran

32 Internal audit followed standard requirements ISIRI-ISO 1393 Institute Pasteur of Iran

33 Design and planning in laboratory quality 1393 Institute Pasteur of Iran

34 Biosafety and Biosecurity Workshop in clinical and research

laboratories 1394 Institute Pasteur of Iran

35 Understanding DNA sequencing and its application 1394 Institute Pasteur of Iran

36 Global Summit for TQM 1393 IRIB International Center of the Islamic Republic of Iran

37 Effective communication organization 1391 Institute Pasteur of Iran

38 operational budgeting 1390 Institute Pasteur of Iran

39 Understanding and working with electron microscopy, SEM 1393 Institute Pasteur of Iran

40 Seminar with the principles of quality management and internal

audit based on standard requirements 1393 Institute Pasteur of Iran